Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKA | O14965 | 14/20 | 0.47 |
| ▸ | AURKB | Q96GD4 | 6/20 | 0.46 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.46 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.46 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.46 |
| ▸ | RET | P07949 | 1/20 | 0.46 |
| ▸ | HCK | P08631 | 1/20 | 0.46 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.46 |
| ▸ | FLT4 | P35916 | 1/20 | 0.46 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.46 |
| ▸ | SIK1 | P57059 | 1/20 | 0.46 |
| ▸ | TNK2 | Q07912 | 1/20 | 0.46 |
| ▸ | WNK3 | Q9BYP7 | 1/20 | 0.46 |
| ▸ | DNMT1 | P26358 | 5/20 | 0.41 |
| ▸ | DNMT3A | Q9Y6K1 | 4/20 | 0.41 |
| ▸ | DNMT3L | Q9UJW3 | 2/20 | 0.41 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.39 |
| ▸ | MYC | P01106 | 1/20 | 0.38 |
| ▸ | MAP2K3 | P46734 | 1/20 | 0.38 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11886910 | 0.88 | AURKA (0.43) | AURKAAURKBMAPK13CHEK2NTRK1 | |
| SCHEMBL11028172 | 0.84 | AURKA (0.53) | AURKAAURKBMAPK13CHEK2NTRK1 | |
| SCHEMBL1161178 | 0.81 | AURKA (0.53) | AURKAAURKBCHEK2NTRK1RET | |
| SCHEMBL11032000 | 0.80 | AURKA (0.51) | AURKAAURKBMAPK13CHEK2NTRK1 | |
| SCHEMBL11030391 | 0.79 | AURKA (0.49) | AURKAAURKBMAPK13CHEK2NTRK1 | |
| SCHEMBL1161096 | 0.78 | AURKA (0.51) | AURKAAURKBMAPK13CHEK2NTRK1 | |
| SCHEMBL1160911 | 0.76 | AURKA (0.57) | AURKAAURKBMAPK13CHEK2NTRK1 | |
| SCHEMBL1160863 | 0.76 | AURKA (0.49) | AURKAAURKBMAPK13CHEK2NTRK1 | |
| SCHEMBL11031533 | 0.75 | AURKA (0.56) | AURKAAURKBMAPK13CHEK2NTRK1 | |
| SCHEMBL1161182 | 0.73 | AURKA (0.51) | AURKAAURKBMAPK13CHEK2NTRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8569295-B2 | Bicyclic urea compounds | MERCK PATENT GMBH (DE) | 2013-10-29 | — | — | US | claimed |
| EP-2461869-B1 | NOVEL BICYCLIC UREA COMPOUNDS | MERCK PATENT GMBH (DE) | 2013-08-21 | — | — | EP | claimed |
| US-20120190654-A1 | NOVEL BICYCLIC UREA COMPOUNDS | MERCK PATENT GMBH (DE) | 2012-07-26 | — | — | US | claimed |
| US-8569295-B2 | Bicyclic urea compounds | MERCK PATENT GMBH (DE) | 2013-10-29 | — | — | US | disclosed |
| EP-2461869-B1 | NOVEL BICYCLIC UREA COMPOUNDS | MERCK PATENT GMBH (DE) | 2013-08-21 | — | — | EP | disclosed |
| US-20120190654-A1 | NOVEL BICYCLIC UREA COMPOUNDS | MERCK PATENT GMBH (DE) | 2012-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120190654-A1 | NOVEL BICYCLIC UREA COMPOUNDS | CCNC, CCNI, CCNA1 | AURKA 566/4885AURKB 446/4885MAPK13 1022/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.